Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Investigation

• Publication date

  2004-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI19639PMID 14722612PMCID PMC311432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Sandhoff disease].

  2019cited by this paper
• Gene therapy for lysosomal storage disorders.

  2013cited by this paper
• Gene therapy for lysosomal storage disorders

  2003cited by this paper
• Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease

  2003cited by this paper
• Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.

  2003influential reference
• Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal‐regulating kinase 1 during seizure‐induced neuronal death

  2003cited by this paper
• Lysosomal storage results in impaired survival but normal neurite outgrowth in dorsal root ganglion neurones from a mouse model of Sandhoff disease

  2002influential reference
• Roles of Fc receptors in autoimmunity

  2002cited by this paper
• What is the basis of transmissible spongiform encephalopathy induced neurodegeneration and can it be repaired?

  2002cited by this paper
• Fc Receptors are Critical for Autoimmune Inflammatory Damage to the Central Nervous System in Experimental Autoimmune Encephalomyelitis

  2002cited by this paper
• Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.

  2002cited by this paper
• Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling.

  2002cited by this paper
• Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.

  2001influential reference
• The effects of the Na(+)/Ca(++) exchange blocker on osmotic blood-brain barrier disruption.

  2001cited by this paper
• IgG Fc receptors.

  2001cited by this paper
• Peripheral Neuropathy Associated with Anti-GM2 Ganglioside Antibodies: Clinical and Immunopathological Studies

  2000cited by this paper
• Features of systemic lupus erythematosus in Dnase1-deficient mice

  2000cited by this paper
• Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.

  2000influential reference
• Lupus, DNase and defective disposal of cellular debris

  2000cited by this paper
• Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases.

  2000cited by this paper
• Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.

  1999cited by this paper
• Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III.

  1999cited by this paper
• Anti‐neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients

  1999cited by this paper
• Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS)

  1999cited by this paper
• Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice.

  1998influential reference
• Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.

  1997cited by this paper
• Daxx, a novel Fas-binding protein that activates JNK and apoptosis.

  1997cited by this paper
• Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.

  1996cited by this paper
• Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism

  1995influential reference
• Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb.

  1994cited by this paper
• FcR γ chain deletion results in pleiotrophic effector cell defects

  1994cited by this paper
• FcR gamma chain deletion results in pleiotrophic effector cell defects.

  1994cited by this paper
• Structure and Expression of the Mouse β-Hexosaminidase Genes, Hexa and Hexb

  1994cited by this paper
• Lysosomal storage diseases: mechanisms of enzyme replacement therapy

  1993cited by this paper
• Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

  1991cited by this paper
• Lysosomal storage diseases.

  1991cited by this paper
• A simple and specific assay of glycosyltransferase and glycosidase activities by an enzyme-linked immunosorbent assay method, and its application to assay of galactosyltransferase activity in sera from patients with cancer.

  1990cited by this paper
• Polyclonal B‐cell lymphocytosis and hypergammaglobulinemia in patients with gaucher disease

  1988cited by this paper
• Lysosomal storage diseases.

  1986influential reference
• SANDHOFF DISEASE

  1981cited by this paper
• Quantitative aspects of reversible osmotic opening of the blood-brain barrier.

  1980cited by this paper
• Inborn errors of mucopolysaccharide metabolism.

  1970cited by this paper

• Therapeutic targeting of neuroinflammation in sphingolipidosis.

  2025cites this paper
• Infection of a β-galactosidase-deficient mouse strain with Theiler’s murine encephalomyelitis virus reveals limited immunological dysregulations in this lysosomal storage disease

  2025cites this paper
• Stress-induced heme metabolic disorder in peripheral B cells contributes to depressive-like behaviors in male mice.

  2025cites this paper
• [Pathophysiology of Sandhoff Disease and Novel Thrapeutic Targets].

  2023cites this paper
• Sphingolipid abnormalities in encephalomyeloradiculoneuropathy (EMRN) are associated with an anti‐neutral glycolipid antibody

  2023cites this paper
• Exploring Pro-Inflammatory Immunological Mediators: Unraveling the Mechanisms of Neuroinflammation in Lysosomal Storage Diseases

  2023cites this paper
• Real-world patient data on immunity and COVID-19 status of patients with MPS, Gaucher, and Pompe diseases from Turkey

  2022cites this paper
• The role of brain innate immune response in lysosomal storage disorders: fundamental process or evolutionary side effect?

  2020cites this paper
• Abnormal organization during neurodevelopment in a mouse model of Sandhoff disease.

  2020cites this paper
• Screening for Fabry Disease in Patients With Juvenile Systemic Lupus Erythematosus.

  2020cites this paper
• GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies

  2020influential citation
• Glycosphingolipids and neuroinflammation in Parkinson’s disease

  2020cites this paper
• GM2 Gangliosidosis: Clinical Features and Current Therapies

  2020influential citation
• Prevalence of antibodies to ganglioside and Hep 2 in Gaucher, Niemann – Pick type C and Sanfilippo diseases

  2019cites this paper
• Genetics and Therapies for GM2 Gangliosidosis

  2018cites this paper
• Two‐Year Follow‐Up Magnetic Resonance Imaging and Spectroscopy Findings and Cerebrospinal Fluid Analysis of a Dog with Sandhoff's Disease

  2018cites this paper
• Improvement in dysmyelination by the inhibition of microglial activation in a mouse model of Sandhoff disease

  2018cites this paper
• Inhibition of astrocytic adenosine receptor A2A attenuates microglial activation in a mouse model of Sandhoff disease.

  2018cites this paper
• Lysosomal storage diseases

  2018cites this paper
• Emptying the stores: lysosomal diseases and therapeutic strategies

  2017cites this paper
• FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice

  2017cites this paper
• Overview of immune abnormalities in lysosomal storage disorders.

  2017cites this paper
• Suppression of NK and CD8+ T cells reduces astrogliosis but accelerates cerebellar dysfunction and shortens life span in a mouse model of Sandhoff disease.

  2017cites this paper
• Abnormal differentiation of Sandhoff disease model mouse-derived multipotent stem cells toward a neural lineage

  2017cites this paper
• Functional evaluation of yuzu (Citrus junos) extracts containing limonoids and polyamine for life extension

  2017cites this paper
• Accumulated α-synuclein affects the progression of GM2 gangliosidoses.

  2016cites this paper
• Pathogenic role of ganglioside metabolism in neurodegenerative diseases

  2014cites this paper
• Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity

  2014cites this paper
• Secondary biochemical and morphological consequences in lysosomal storage diseases

  2014cites this paper
• [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].

  2013cites this paper
• The cellular pathology of lysosomal diseases

  2012cites this paper
• [Glycobiology and neurological disorders].

  2011cites this paper
• Thymic involution and corticosterone level in Sandhoff disease model mice: new aspects the pathogenesis of GM2 gangliosidosis

  2011influential citation
• Treating inflammation in childhood neurodegenerative disorders

  2011cites this paper
• Thymic Alterations in GM2 Gangliosidoses Model Mice

  2010cites this paper
• Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases*

  2010cites this paper
• Unilaterally and rapidly progressing white matter lesion and elevated cytokines in a patient with Tay-Sachs disease.

  2010cites this paper
• Systems biology and its application to the understanding of neurological diseases

  2009cites this paper
• Treating lysosomal storage disorders: current practice and future prospects.

  2009cites this paper
• Immune system irregularities in lysosomal storage disorders

  2008cites this paper
• Involvement of Retinal Neurons and Pigment Epithelial Cells in a Murine Model of Sandhoff Disease

  2008cites this paper
• [Recent topics on paraneoplastic neurological syndromes: anti-glycolipid antibodies].

  2008cites this paper
• Early deficits in motor coordination and cognitive dysfunction in a mouse model of the neurodegenerative lysosomal storage disorder, Sandhoff disease.

  2008cites this paper
• High incidence of autoantibodies in Fabry disease patients

  2007cites this paper
• Pathology of Mucopolysaccharidosis IIIA in Huntaway Dogs

  2007cites this paper
• The GM2 Gangliosidoses

  2007cites this paper
• Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.

  2007cites this paper
• Leukocyte and complement activation by GM1-specific antibodies is associated with acute motor axonal neuropathy in rabbits.

  2007cites this paper
• IgG entry and deposition are components of the neuroimmune response in Batten disease.

  2007influential citation
• Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen.

  2007cites this paper
• Neuronal and glial accumulation of α- and β-synucleins in human lipidoses

  2007cites this paper
• Detection of new anti‐neutral glycosphingolipids antibodies and their effects on Trk neurotrophin receptors

  2006cites this paper
• The Human Obesity Gene Map: The 2005 Update

  2006influential citation
• Pathogenic autoantibodies: emerging insights into tissue injury.

  2006cites this paper
• Distinct patterns of serum immunoreactivity as evidence for multiple brain‐directed autoantibodies in juvenile neuronal ceroid lipofuscinosis

  2006cites this paper
• Effective gene therapy in an authentic model of Tay-Sachs-related diseases

  2006cites this paper
• Storage solutions: treating lysosomal disorders of the brain

  2005cites this paper
• Impaired neurite outgrowth in the retina of a murine model of Sandhoff disease.

  2005cites this paper
• Fc Receptors and Their Role in Immune Regulation and Autoimmunity

  2005cites this paper
• Specific induction of macrophage inflammatory protein 1‐α in glial cells of Sandhoff disease model mice associated with accumulation of N‐acetylhexosaminyl glycoconjugates

  2005cites this paper
• NSAIDs increase survival in the Sandhoff disease mouse: Synergy with N‐butyldeoxynojirimycin

  2004cites this paper
• Myositis and myopathies

  2003cites this paper